High-throughput Phenotyping of Lung Cancer Somatic Mutations
Berger, A. H., A. N. Brooks, X. Wu, Y. Shrestha, C. Chouinard, F. Piccioni, M. Bagul, et al. 2017. “High-Throughput Phenotyping of Lung Cancer Somatic Mutations”. Cancer Cell 32: 884.
Search
Search results
607 results found
Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells
Berger, R., P. G. Febbo, P. K. Majumder, J. J. Zhao, S. Mukherjee, S. Signoretti, K. T. Campbell, et al. 2004. “Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells”. Cancer Res 64: 8867-75.
Metagenes and molecular pattern discovery using matrix factorization
Brunet, J. P., P. Tamayo, T. R. Golub, and J. P. Mesirov. 2004. “Metagenes and Molecular Pattern Discovery Using Matrix Factorization”. Proc Natl Acad Sci U S A 101: 4164-9.
Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution
Byers, R. J., D. Di Vizio, F. O’Connell, E. Tholouli, R. M. Levenson, K. Gossage, D. Twomey, et al. 2007. “Semiautomated Multiplexed Quantum Dot-Based in Situ Hybridization and Spectral Deconvolution”. J Mol Diagn 9: 20-9.
AACR Cancer Progress Report 2012
Cantley, L. C., W. S. Dalton, R. N. DuBois, O. J. Finn, P. A. Futreal, T. R. Golub, W. N. Hait, et al. 2012. “AACR Cancer Progress Report 2012”. Clin Cancer Res 18: S1-100.
The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways
Carroll, M., M. H. Tomasson, G. F. Barker, T. R. Golub, and D. G. Gilliland. 1996. “The TEL/Platelet-Derived Growth Factor Beta Receptor (PDGF Beta R) Fusion in Chronic Myelomonocytic Leukemia Is a Transforming Protein That Self-Associates and Activates PDGF Beta R Kinase-Dependent Signaling Pathways”. Proc Natl Acad Sci U S A 93: 14845-50.
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., M. S. Lawrence, J. J. Keats, K. Cibulskis, C. Sougnez, A. C. Schinzel, C. L. Harview, et al. 2011. “Initial Genome Sequencing and Analysis of Multiple Myeloma”. Nature 471: 467-72.
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Chapuy, B., M. G. Roemer, C. Stewart, Y. Tan, R. P. Abo, L. Zhang, A. J. Dunford, et al. 2016. “Targetable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas”. Blood 127: 869-81.
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors
Chattopadhyay, S., A. L. Stewart, S. Mukherjee, C. Huang, K. A. Hartwell, P. G. Miller, R. Subramanian, et al. 2015. “Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor With Improved Selectivity over Hematopoietic Progenitors”. Cell Rep 10: 755-70.
The Drug Repurposing Hub: a next-generation drug library and information resource
Corsello, S. M., J. A. Bittker, Z. Liu, J. Gould, P. McCarren, J. E. Hirschman, S. E. Johnston, et al. 2017. “The Drug Repurposing Hub: A Next-Generation Drug Library and Information Resource”. Nat Med 23: 405-8.